You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥易購(300937.SZ):正在通過“資本+業務”相結合的模式積極拓展四川省外的醫藥商業合作伙伴
格隆匯 05-18 07:37

格隆匯5月18日丨有投資者在投資者互動平台向藥易購(300937.SZ)提問,“公司前期公吿已在河南省開展線上藥品業務,請問目前在河南的業務開展是否順利?業務量有多大?下一步是否有在其他省份推廣拓展業務的計劃?”

藥易購回複稱,公司於2022年12月27日召開的第三屆董事會第六次會議審議通過了《關於轉讓控股子公司股權的議案》,公司將持有的合縱藥易購(河南)醫藥有限公司(以下簡稱“合縱河南”)58.02%的股份轉讓後,公司不再持有合縱河南股份,合縱河南將不再納入公司合併報表範圍,相關財務數據詳見公司年度報吿。目前,公司正在通過“資本+業務”相結合的模式積極拓展四川省外的醫藥商業合作伙伴,利用公司成熟高效的B2B電商技術和運營經驗,與合作伙伴共同拓展省外醫藥終端市場,跨區域佈局B2B電商平台,實現公司的跨區域經營,後續進展情況公司將按照相關法律法規要求及時履行信息披露義務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account